MGMT and central nervous system cancer: Frequency of IDH1 mutation, MGMT promoter methylation and PD-L1 expression status: among a total 35 glioma cases, the frequency of IDH1, MGMT promoter methylation and PD-L1 expression status of glioma patients were represented in Figure 2.